HB470 Alabama 2022 Session
In Committee
Bill Summary
Sponsors
Session
Regular Session 2022
Title
COVID-19, occupational licensing boards prohibited to take adverse action based on physician's recommended COVID-19 treatment, health care facilities and pharmacies required to fulfill patient's COVID-19 treatment request, cause of action provided
Description
<p class="bill_description"> This bill would prohibit an occupational
licensing board from taking adverse action against
a physician who recommends a COVID-19 treatment
that is not FDA-approved</p><p class="bill_description">
This bill would require a patient's written,
informed consent to receive a physician's
recommended COVID-19 treatment if the treatment is
not FDA-approved</p><p class="bill_description">
This bill would require pharmacies to
fulfill prescriptions that are not FDA-approved to
treat COVID-19</p><p class="bill_description">
This bill would require health care
facilities to provide a patient's requested
off-label use COVID-19 treatment</p><p class="bill_description">
This bill would provide a cause of action
against an occupational licensing board, pharmacy,
or health care facility that violates the
provisions of this bill</p><p class="bill_entitled_an_act"> Relating to COVID-19; to prohibit an occupational
licensing board from taking adverse action against a physician
who recommends certain COVID-19 treatments; to require a
patient's written, informed consent to certain COVID-19
treatments; to require health care facilities and pharmacies
to provide certain COVID-19 treatments that are not approved
by the FDA; and to create a cause of action.
</p>
Subjects
Covid-19
Bill Actions
| Action Date | Chamber | Action |
|---|---|---|
| March 8, 2022 | H | Read for the first time and referred to the House of Representatives committee on Judiciary |
Bill Text
Bill Documents
| Type | Link |
|---|---|
| Bill Text | HB470 Alabama 2022 Session - Introduced |